Hurotics has earned recognition at CES 2025 with two awards for its AI-powered wearable rehabilitation robot, H-Medi. Designed to provide personalized gait therapy, the device combines advanced AI algorithms with a portable, user-friendly design, enhancing rehabilitation outcomes for patients with mobility challenges. Backed by clinical partnerships and ongoing certifications, it addresses the growing need for accessible solutions in a rapidly aging society.
Setting New Standards in Medical Robotics at CES 2025
CES 2025, hosted by the Consumer Technology Association (CTA) in Las Vegas, remains the world’s leading stage for groundbreaking consumer electronics and IT solutions. This year, Hurotics captured significant attention by winning two CES Innovation Awards in Accessibility & AgeTech and Robotics categories. The company’s wearable rehabilitation robot, H-Medi, earned accolades for its advanced technology and user-centric design.
Hurotics’ back-to-back CES wins underscore its commitment to delivering innovative solutions in wearable robotics, firmly establishing its presence in the global medical device market.
What Makes H-Medi a Game-Changer in Rehabilitation?
H-Medi distinguishes itself as a comprehensive wearable medical robot designed to streamline the entire rehabilitation process for gait disorders. Unlike traditional bulky devices, this lightweight solution is portable and resembles everyday clothing, ensuring comfort and ease of use.
Its innovative design eliminates the need for large installations, making it accessible for diverse settings such as hospitals and rehabilitation centers. Patients benefit from active gait training without the constraints of traditional machinery.
AI-Driven Precision for Effective Rehabilitation
H-Medi integrates advanced AI algorithms that analyze gait patterns with 92% accuracy in predicting disease prognosis. Within two minutes, the system delivers personalized therapy recommendations tailored to the patient’s needs.
Its adaptive algorithms provide 95% accuracy in supporting gait improvements, enhancing walking speed by over 10% and gait efficiency by 21%. These precise adjustments ensure effective and individualized therapy sessions, contributing to faster recovery and improved mobility.
Recommended: Samsung Vision AI Delivers Smarter Screens For Personalized Home Entertainment
Collaborations and Medical Validation
The development of H-Medi is backed by collaborations with Chung-Ang University Hospital, Chung-Ang University, and RoboWell Korea, under the Pan-Ministry Medical Device Development Program. These partnerships have driven the device’s robust clinical evaluation and refinement.
H-Medi has achieved Grade 1 medical device certification, with Grade 2 evaluation and FDA approval processes currently in progress. The robot’s effectiveness has also been recognized through publication in Science, highlighting its ability to aid walking in patients with sarcopenia and mild mobility impairments.
Tackling Gait Disorders in a Super-Aged Society
As global aging accelerates, gait disorders are becoming an increasingly critical healthcare challenge. H-Medi’s wearable and portable nature enables therapy beyond the confines of clinical environments, empowering patients to continue rehabilitation at home.
By integrating precise AI-driven solutions with an accessible design, H-Medi offers a pathway to improved mobility and independence for elderly populations. Its capacity to adapt to diverse needs highlights its role in meeting the demands of a super-aged society.
Redefining Success in Wearable Medical Robotics
Hurotics’ CEO, Giuk Lee, emphasized the importance of practical and accessible solutions in wearable robotics. The dual recognition at CES 2025 reflects the company’s commitment to developing devices that improve lives and meet pressing healthcare demands.
With H-Medi, Hurotics showcases a vision for the future of medical robotics, blending cutting-edge technology with patient-focused innovation. By combining accessibility, precision, and advanced AI capabilities, the company solidifies its position as a leader in wearable medical devices, addressing a growing global need.
Please email us your feedback and news tips at hello(at)techcompanynews.com